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Abstract Gold nanoparticles are considered to be real
jewels. The significant growth of their application for
labeling, delivery, heating, and sensing shows their signif-
icance in biology and/or life sciences. PEGylated gold
nanoparticles also have significant application in drug and
gene delivery. However, comprehensive information on the
compatibility of these nanoparticles to blood is limited in
literature. An attempt has been made to study the protein
adsorption, blood cell aggregation, and C3 adsorption onto
these particles to evaluate its complement activation
potential and blood compatibility. It has been observed that
these nanoparticles do not induce any complement activa-
tion or blood cell aggregation. Particles were non-hemolytic
and the adsorptions of proteins were negligible which
further validates its significance in drug delivery and gene
delivery applications.
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Introduction
In recent years, there has been a significant increase in
nanoparticle research due to their beneficial applications in
the fields of biomedical, bioanalytical, and biosensing.
Metallic nanoparticles including gold nanoparticles (GNP)
show optical plasmon resonance, which makes them
suitable for applications in the biological fields like
chemical and biological sensing, surface enhanced spec-
troscopy, bio tagging, and drug delivery [1]. In recent times
biosensors have attracted much attention due to their
applicability in clinical diagnostics, pharmaceuticals, and
in the food industry [2, 3]. GNPs have a wide range of
applications as they exhibit a high surface plasmon
resonance in aqueous media. Since the light-scattering
signal is intense and much brighter than chemical fluoro-
phores, it is mainly applied in single-molecule imaging,
where the use of dyes, fluorophores, or quantum dots is
limited by low signal intensities [4]. The GNPs find
significant applications also in drug delivery as they are
capable of encapsulating active drugs and targeting [5].
Colloidal GNPs represent a completely novel technology in
the field of particle-based tumor-targeted drug delivery.
GNPs are found to be more stable when they are covalently
coupled with thiol entities. The presence of the thiol groups
on the surface reduces the formation of aggregates [6, 7].
The monolayer of polyethylene glycol (PEG) over GNP has
been found to improve the cellular internalization properties
[8]. Surface modification of gold nanoparticulate carriers
with PEG [9] has emerged as a strategy to enhance
solubility of hydrophobic drugs, prolong circulation time,
minimize non-specific uptake, and allow for specific tumor
targeting through the enhanced permeability and retention
effect. PEG modification on thiolated GNPs can be used as
drug and gene carriers with specific tumor targeting
properties through a flexible tether, promoting tumor-
targeting capabilities, thereby enhancing efficacy of anti-
cancer therapeutic strategies [10]. Nanoparticles of gold are
attracting increased attention in nanotechnology, but there
are applications in medicine that are still relatively
unexplored [11, 12]. However, ionic forms of gold have
been shown to have cytotoxicity on various cell types and
adverse effects on red blood cells (RBC) [13]. Earlier
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reviews suggest that GNPs bind to thiol groups and, applying
a coating on the surface, reduce aggregation and give stability
to the nanoparticles [14]. PEGylation helps to reduce the
toxicity and improve blood compatibility [15]. Hence, an
attempt has been made to study the blood compatibility of
the gold and PEGylated gold nanoparticles (pGNP). The
blood compatibility studies that have been done are
hemolysis, aggregation studies of blood cells, protein
adsorption and complement C3 adsorption studies, etc.
Materials and methods
Gold (III) chloride hydrate (HAuCl4) was purchased from
Spectrochem India Pvt. Ltd. 11-Mercaptoundecanoic acid,
O-(2-aminoethyl) O′-methyl polyethylene glycol (MW
20,000) (amino-PEG) and 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC) were obtained from Sigma Chemical
Co. USA. Complement protein C3 kit was purchased from
Orion Diagnostica, Finland. All other chemicals and other
reagents used were of analytical reagent grade.
Preparation of gold nanoparticles
The GNPs were prepared by the standard procedure of
reduction with citrate [16]. Briefly, 20 ml of 1 mM solution
of gold chloride (HAuCl4) was allowed to boil and 2 ml of
1% trisodium citrate solution was added dropwise. The
heating was continued for half an hour until a deep wine
red color appeared.
Preparation of PEGylated gold nanoparticles
To 40 ml of 10 mM HAuCl4 solution in methanol, 10 mM
11-mercaptoundecanoic acid in methanol (10 ml) was
added and stirred well. Twenty-five milliliters of 0.3 M
aqueous solution of sodium borohydride (NaBH4) was
added dropwise with vigorous stirring for 1 h. The
nanoparticles obtained were centrifuged and washed with
methanol to remove the excess thiol present in the reaction
mixture. In 50 mg of these thiolated gold nanoparticles,
0.04 M EDC in 5 ml of phosphate buffer (pH 6.8) was
added and stirred well for 2 h. One hundred milligrams of
amino-PEG was added and stirred overnight. It was then
filtered through a centrifugal filter (30 kD), washed in 6.8
pH buffer and finally freeze-dried.
Particle size and zeta potential determination by photon
correlation spectroscopy and laser Doppler anemometry
The particle size and the zeta potential of the gold
nanoparticles (GNP) and pGNP were analyzed by photon
correlation spectroscopy and laser Doppler anemometry,
respectively, with a Zetasizer, Nano ZS (Malvern Instruments
Limited, UK) at 25°C.
UV-visible spectroscopy
The visible absorption spectra of GNP and pGNP suspensions
were obtained by UV-Vis spectrophotometer (Varian).
Blood compatibility studies
Blood cell aggregation and hemolysis studies RBCs were
separated by centrifuging fresh blood at 700 rpm. This was
Fig. 1 Particle size distributions of GNPs and pGNPs obtained via
photon correlation spectroscopy
Fig. 2 Transmission electron micrograph of GNPs
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washed with saline and diluted in saline in a ratio of 1:4.
White blood cells (WBC) were isolated by centrifuging the
fresh blood after layering with histopaque for 20 min at
700 rpm. Platelet rich plasma (PRP) was collected by
centrifuging the fresh blood at 1,000 rpm for 20 min
layered on histopaque solution. In 1 mg each of gold and
pGNP, 100 μl of the diluted RBC, WBC suspension, or
PRP were added and incubated for 30 min at 37°C.
Polyethyleneimine (PEI) and saline were taken as positive
and negative controls, respectively for all studies. Aggre-
gations, if any, were observed through a phase contrast
microscope (Leica DM IRB, Germany) at a magnification
of ×40. Hemolysis assay was done on the nanoparticles as
reported elsewhere [16]. Normal saline was used as
negative control (0% lysis) and distilled water as positive
control (100% lysis). The absorbance was measured at
541 nm by UV-Vis spectrophotometer (Varian).
Protein adsorption studies The plasma was separated by
centrifugation of fresh blood at 700 rpm. Ten milligrams
each of the nanoparticles were dispersed in 200 μl of saline.
To this, 200 μl of plasma was added and incubated for 1 h.
After incubation, the plasma was separated by centrifuga-
tion at 10,000 rpm and diluted with saline. The proteins in
the plasma samples before and after incubation were
separated by polyacrylamide gel electrophoresis (PAGE)
using discontinuous native PAGE method of Laemmli [17].
A resolving gel of 12% and a stacking gel 4% were used.
Electrophoresis was carried out at 100V for 90 min using
Fig. 4 Aggregation of RBCs by incubation of a GNPs, b pGNPs, c normal saline (negative control), and d polyethyleneimine (positive control)
Fig. 3 Visible absorption spectra of GNPs and pGNPs
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Mini-PROTEAN II electrophoresis cell (Bio-Rad, CA,
USA). The gel was digitalized using an image analyzer
(LAS 4000, Fuji) and the densitometry scans were done
with the software Multi Gauge V3.
Complement activation The complement activation of the
nanoparticles was determined by turbidimetric method assess-
ing the depletion of complement protein C3 on incubation
with the nanoparticles. The particle suspensions (100 μl) were
incubated for 1 h at 37°C with 100 μl of citrated blood. The
final concentration of the nanoparticles in the assay system
was maintained at 10 μg/ml of blood. The assay was done as
per the protocol provided by the kit manufacturer.
Results and discussion
The gold nanoparticles were prepared by the standard
procedure of reducing of Au3+ ions to gold in the presence
of citrate. The citrate has also acted as a stabilizing agent,
by forming a layer of citrate ions on the GNP preventing
the aggregation of the nanoparticles. For the preparation of
pGNP initially the gold chloride was modified with 11-
mercaptoundecanoic acid to form thiolated GNP. Thiolated
GNPs were further modified with amino-PEG after activating
the carboxyl groups with water-soluble EDC. The particle size
distributions of the nanoparticles are shown in Fig. 1. GNPs
and pGNPs had mean diameters of 21.04 and 32.67 nm,
respectively. A representative transmission electron micro-
graph of GNP is given in Fig. 2. The zeta potentials of
nanoparticles at neutral pH (pH 7) were found to be −47 and
−22 mV, respectively for GNPs and pGNPs. The increase in
the zeta potential is an indication of PEGylation of the GNPs.
Formation of PEG monolayer over GNPs has been reported
to improve the cellular internalization properties [18].
The visible absorption spectrum obtained from UV-
visible spectrophotometer showed a red shift in the
wavelength for the pGNPs as demonstrated in Fig. 3. The
GNPs showed an absorption peak at around 523 nm, and
for the pGNP particles, a peak at 541 nm was observed.
This is consistent with the obtained particle size distribu-
tions and again confirmed the PEGylation of GNPs. For
larger nanoparticles (d>25 nm), the extinction cross section
is dependent on higher-order multipole modes within the
full Mie equation and the extinction spectrum is then also
dominated by quadrupole and octopole absorption as well
as scattering. These higher oscillation modes explicitly
Fig. 5 Aggregation of WBC by incubation of a GNPs, b pGNPs, c normal saline (negative control), and d polyethyleneimine (positive control)
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depend on the particle size and with increasing size the
plasmon absorption maximum is shifted to longer wavelength
and the bandwidth increases [19–21].
The aggregations of the blood cells on interaction with
the nanoparticles are shown in Figs. 4, 5 and 6, respectively
for RBCs, WBCs, and platelets. It revealed no aggregation
of blood cells on incubation of nanoparticles at a higher
interaction ratio of 10 mg/ml. PEI, which was used as
positive control, showed aggregation whereas saline used as
negative control did not show any aggregation. The same
was visible with the hemolytic property of the nanoparticles.
The hemolysis induced by GNPs was 0.1% and that for
pGNPs was 0.15% which was well within the acceptable
limits of 1% [22].
Measuring C3a or C5a in blood or serum after contact
with a material has been the most usual way of assessing
complement activation. It has been claimed that a surface is
biocompatible if these markers are not increased in the fluid
phase [23]. Since C3 is cleaved to C3a and C3b by the
contact of the surface with blood, irrespective of whether
the activation occurs via classical or alternative pathways,
and also C3a could be adsorbed on to the material surface
just like any other proteins, C3 depletion in the medium can
be taken as an indirect measure of complement activation.
The amount of C3 in blood (pre-incubation) was 127 mg%.
After incubation with GNPs and pGNPs, it was 124 mg%
and 129 mg%, respectively. On incubation of nanoparticles
with blood, no depletion of C3 protein was observed,
Fig. 7 Densitometry scan of native PAGE of plasma proteins before
and after incubation with GNPs and pGNPs
Fig. 6 Aggregation of platelets by incubation of a GNPs, b pGNPs, c normal saline (negative control), and d polyethyleneimine (positive control)
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which indicates that GNPs as well as pGNPs are not
complement activating.
The initial event when a material comes in contact with
blood is the adsorption of proteins. The nature of protein
and amount of protein adsorbed will directly influence the
compatibility of the nanoparticles with the blood. The
adsorption studies evaluated using native PAGE electro-
phoresis demonstrated no significant adsorption of proteins
occurring onto GNPs as well as pGNPs as shown in the
densitometry scan of the treated plasma (Fig. 7). There was
a correlation of the adsorption of the globular proteins with
the blood cell aggregation showing no activation or
aggregation of cells on incubation with gold nanoparticles.
The results obtained from the blood compatibility evalua-
tion of gold and PEGylated gold support its usage as vectors
for the applications in drug delivery, gene delivery, or as
biosensors, where a direct contact with blood occurs.
Acknowledgment We are grateful to the director and the head of BMT
Wing of SCTIMST for providing facilities for the completion of this
work. This work was supported by the Department of Science and
Technology, Government of India through the project “Facility for nano/
microparticle based biomaterials—advanced drug delivery systems”
#8013, under the Drugs and Pharmaceuticals Research Program.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the original
author(s) and source are credited.
References
1. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ (2008)
Chem Soc Rev 37:1896–1908
2. Gerard M, Chaubey A, Singh R (2002) Biosens Bioelectron 17:345
3. Pandey P, Singh PS, Arya KS, Gupta V, Dutta M, Singh S,
Malhotra BD (2007) Langmuir 23:3333–3337
4. Yguerabide J, Yguerabide EE (1998) Anal Biochem 262:137–
156
5. Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Adv Drug
Deliv Rev 60:1307–1315
6. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin
RE, Tamarkin L (2004) Drug Deliv 11:169–183
7. Shi W, Sahoo Y, Swihart MT (2004) Colloids Surf A Physico-
chem Eng Asp 246:109–113
8. Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim
DL (2007) Anal Chem 79:2221–2229
9. Durgadas CV, Kaladhar K, Divya P, Sreenivasan K, Sharma CP
(2009) Trends Biomater Artif Organs 23:86–92
10. Alcantar NA, Avdil ES, Israelachvili TN (2000) J Biomed Mater
Res 51:343–351
11. Pissuwan D, Valenzuela SM, Cortie MB (2006) Trends Biotechnol
24:62–67
12. Paciotti GF, Kingston DGI, Tamarkin L (2006) Drug Dev Res
67:47–54
13. Garner M, Rglinski J, Smith WE, Stewart MJ (1994) J Inorg
Biochem 56:283–290
14. Johnson SR, Evans SD, Brydson R (1998) Langmuir 14:6639–
6647
15. Lee JH, Lee HB, Andrade JD (1995) Prog Polym Sci 20:1043–
1079
16. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS
(1999) J Control Release 61:137–143
17. Laemmli UK (1970) Nature 227:680–685
18. Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim
DL (2007) Anal Chem 79:2221–2229
19. Kerker M (1969) Light and other electromagnetic radiation.
Academic, New York
20. Bohren CF, Huffman DR (1983) Absorption and scattering of
light by small particles. Wiley, New York
21. Creighton JA, Eadon DG (1991) J Chem Soc Faraday Trans
87:3881–3891
22. ASTM Standard F756-08 (2008) Standard practice for assessment
of hemolytic properties of materials. ASTM International, West
Conshohocken. doi:10.1520/F0756-08
23. Mollnes TE, Riesenfeld J, Garred P (1995) Artif Organs
19:909–917
20 Gold Bull (2011) 44:15–20
